Rejected at 6:31 a.m. Jan, 19, 2024 ] by Cameron
Author: adl002
Related Note: 1483492350779
Rationale for change

The 2016 American College of Physicians (ACP) guidelines recommend steroids as a first-line treatment for all patients because of their significantly lower cost and better safety profile. The 2020 American College of Rheumatology (ACR) guidelines recommend that individual factors (e.g., side effects, contraindications, patient preference) guide the decision of which of these three options to pick, except in the case of NPO patients, for whom parenteral or intraarticular glucocorticoids are preferred.
Source: AMBOSS - https://next.amboss.com/us/article/YT0n62?q=acute%20gout#NJ1-830

Rejection reason

AMBOSS does not say as claimed; resubmit with a link to society guidelines if they really say otherwise...

Text Text
Extra
- Do not use salicylates
- Renal disease/gastritis → cannot use NSAIDs
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid


Sketchy


Watch Gout Drugs
Sketchy 2

Watch Gout & Pseudogout SOAP 
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize





Physeo

Bootcamp



Watch associated Bootcamp video - Pharmacology : Gout Medications
OME

Additional Resources
Empty field
One by one
Empty field
Changed Tags
#AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-inflammatory::02_Gout_drugs #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-Inflammatory::02_Gout_Drugs
#AK_Step2_v12::#NBME::Form14::Section_4 #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::05_Gout_Medications #AK_Step1_v12::#AMBOSS::6hajU4 #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::05_NSAIDs #AK_Step2_v12::#Resources_by_rotation::FM::ome::rheum::monoarticulopathy #AK_Step2_v12::Original_decks::Dorian::fam::nbme #AK_Step1_v12::#UWorld::Step::2091 #AK_Step3_v12::#UWorld::4998 #AK_Step1_v12::#Physeo::09_Pharm::09_Musculoskeletal::08_Acute_and_Chronic_Gout_Treatment #AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::15_Colchicine #AK_Step2_v12::!Shelf::FM::no_dupes #AK_Step2_v12::#Resources_by_rotation::IM::ome::rheum::monoarticuloarthropathy #AK_Step1_v12::#AMBOSS::AUaRfP #AK_Step1_v12::#UWorld::COMLEX::25200 #AK_Step2_v12::#AMBOSS::WB0P-R #AK_Step3_v12::#UWorld::7026 !AK_UpdateTags::Step1decks::Lolnotacop::Drugs #AK_Step2_v12::Original_decks::Dorian::fam::ome::rheum::monoarticulopathy #PANCE::EOR::IM #AK_Step2_v12::Original_decks::Dorian::im::ome::rheum::monoarticuloarthropathy #AK_Step1_v12::#UWorld::Step::860 #AK_Step1_v12::#B&B::14_MSK::03_Pathology::07_Gout_Drugs #AK_Step2_v12::#Resources_by_rotation::FM::nbme #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Step2_v12::#Resources_by_rotation::IM::emma #AK_Step2_v12::#OME::01_Medicine::08_Rheumatology::05_Monoarticuloarthropathy #AK_Step2_v12::#B&B::09_MSK::01_General::03_Gout #AK_Step2_v12::Original_decks::Dorian::im::emma #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Rheumatology::Monoarticular_Arthropathies #AK_Step2_v12::#SketchyIM::07_Rheumatology::02_Crystalline_Disorders::01_Gout_&_Pseudogout_SOAP #AK_Step2_v12::#AMBOSS::-x0D_R #AK_Step1_v12::#UWorld::COMLEX::23972 #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::09_Gout_drugs